Skip to main content
. 2021 May 7;100(18):e25690. doi: 10.1097/MD.0000000000025690

Table 3.

Mean scores at baseline, end of cycle 1, and end of cycle 2 in FACT-L 4.0 items between the 2 groups.

FACT-L subscale Cycle Treatment group (mean ± SD) Control group (mean ± SD) P value
Physical well-being Baseline 21.42 ± 4.17 21.25 ± 4.66 .877
Cycle 1 20.44 ± 3.58 18.56 ± 3.92 .042
Cycle 2 19.28 ± 4.29 16.78 ± 4.12 .017
Social well-being Baseline 14.94 ± 4.14 13.78 ± 3.84 .236
Cycle 1 15.58 ± 3.97 13.69 ± 3.75 .048
Cycle 2 16.19 ± 4.27 13.66 ± 4.09 .015
Emotional well-being Baseline 14.39 ± 4.72 15.19 ± 4.08 .461
Cycle 1 15.89 ± 3.09 14.19 ± 3.85 .047
Cycle 2 16.94 ± 3.10 13.81 ± 2.75 4.29E-05
Functional well-being Baseline 14.67 ± 5.19 13.78 ± 3.97 .437
Cycle 1 15.42 ± 4.51 13.03 ± 4.31 .030
Cycle 2 15.58 ± 4.58 12.28 ± 4.08 .003
Lung cancer symptom Baseline 23.81 ± 3.37 22.44 ± 4.12 .137
Cycle1 23.67 ± 3.31 20.75 ± 3.27 .001
Cycle 2 22.78 ± 3.46 19.34 ± 4.57 .001
Total Baseline 89.22 ± 14.15 86.44 ± 14.58 .427
Cycle 1 91.00 ± 12.12 80.22 ± 12.82 .001
Cycle 2 90.78 ± 12.66 75.88 ± 12.86 9.11E-06

FACT-L4.0 = Functional Assessment of Cancer Therapy-Lung version 4.0.